Human Growth Hormone Market Trends 2022-27: Size, Growth, Opportunity and Forecast

 According to IMARC Group’s latest report, titled “Human Growth Hormone Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global human growth hormone market reached a value of US$ 4.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2027, exhibiting a CAGR of 8.47% during 2022-2027.

The human growth hormone (HGH), or somatotropin, refers to a peptide hormone secreted by the pituitary gland for stimulating growth in individuals. Irregular sleep routines, exercise, stress, and low glucose levels are some factors that affect the HGH levels in the human body. Such deficiency can cause reduced energy levels, distorted body composition, resistance to insulin, osteoporosis, lipid abnormalities, and short-bowel syndrome. Therefore, HGH deficiency is treated by extensively administering recombinants through subcutaneous injection to regulate, regenerate, repair, and reproduce cells, increase muscle strength, and improve metabolism, overall body growth, and composition.

Request for a PDF sample of this report: https://www.imarcgroup.com/human-growth-hormone-market/requestsample

Human Growth Hormone Market Trends:

With the increasing prevalence of genetic and hormonal disorders, including Prader-Willi syndrome, Turner syndrome, growth retardation, and pituitary dysfunctions, there has been a rising need for novel HGH vaccines for treatment purposes across the globe. Additionally, growing health concerns and awareness amongst consumers regarding the availability of early-growth hormone therapies and medications is acting as another growth-inducing factor. Moreover, the extensive utilization of deoxyribonucleic acid (DNA) recombinant by pharmaceutical companies as an HGH treatment for adults and children is impelling the market growth. Furthermore, favorable initiatives undertaken by governments to sensitize individuals regarding growth hormone deficiency are impelling the market growth. Besides this, the extensive investments in research and development (R&D) activities to engineer long-lasting synthetic drug therapies to fuel the production of growth hormones are supporting the market growth.


Human Growth Hormone Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

  • Eli Lilly and Company
  • EMD Serono Inc.
  • F. Hoffmann-La Roche AG
  • Ferring B.V.
  • Genentech Inc.
  • Ipsen
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • Sandoz

Market Segmentation:

Breakup by Application:

  • Growth Hormone (GH) Deficiency
    • Adult GH Deficiency
    • Pediatric GH Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature (ISS)
  • Prader-Willi Syndrome (PWS)
  • Small for Gestational Age
  • Others 

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others 

Breakup by Route of Administration:

  • Intravenous
  • Intramuscular
  • Subcutaneous
  • Oral

Regional Insights:

  • North America
  • Western Europe
  • Asia Pacific
  • Latin America
  • Eastern Europe
  • Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/human-growth-hormone-market

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Market Trends
  • Market Drivers and Success Factors
  • Impact of COVID-19
  • Value Chain Analysis
  • Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

30 N Gould St Ste R

Sheridan, WY 82801 USA – Wyoming

Email: Sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800

Comments

Popular posts from this blog

Dairy Market Share, Analysis and Forecast 2022-2027

Gin Market Size US$ 20.2 Billion, Growth Rate (CAGR) of 4.6%, Top Companies and Forecast Report 2023-2028

Risk-based Authentication Market Size, Latest Research Report, Key Players and Demand 2024-32